Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-21 8:26 pm Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNA | Merchant Fahar | 20,244,255 29.1% | 1,704,223 (+9.19%) | View |
2024-02-07 6:55 pm Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNA | HIRSCHMAN ORIN | 4,672,075 6.7% | 242,092 (+5.46%) | View |
2023-02-15 06:35 am Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNA | HIRSCHMAN ORIN | 4,429,983 6.4% | 516,829 (+13.21%) | View |
2023-02-14 2:30 pm Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNA | Merchant Fahar | 18,540,032 25.7% | 365,664 (+2.01%) | View |
2022-10-20 06:02 am Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNA | HIRSCHMAN ORIN | 3,913,154 5.6% | 3,913,154 (New Position) | View |
2022-02-10 2:48 pm Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNA | Merchant Fahar | 18,174,368 31.5% | 239,368 (+1.33%) | View |
2021-02-12 4:24 pm Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNA | Merchant Fahar | 17,935,000 32.7% | 17,935,000 (New Position) | View |